Cambridge Investment Research Advisors, Inc. - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 118 filers reported holding VIKING THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$223
+134.7%
13,741
+35.9%
0.00%
Q4 2022$95
-99.7%
10,113
-6.5%
0.00%
Q3 2022$29,000
-12.1%
10,814
-4.4%
0.00%
Q2 2022$33,000
-2.9%
11,3130.0%0.00%
Q1 2022$34,000
-34.6%
11,3130.0%0.00%
Q4 2021$52,000
-25.7%
11,313
+1.8%
0.00%
Q3 2021$70,000
+7.7%
11,113
+1.7%
0.00%
Q2 2021$65,000
-27.0%
10,928
-22.3%
0.00%
Q1 2021$89,000
-37.3%
14,063
-1.5%
0.00%
-100.0%
Q1 2019$142,00014,2750.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders